淋巴细胞主动免疫治疗对反复自然流产的疗效分析及其护理策略
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
·论著·淋巴细胞主动免疫治疗对反复自然流产的
疗效分析及其护理策略
黄华英 孙鸿燕 廖运梅
【摘要】 目的 探讨采用淋巴细胞主动免疫治疗对反复自然流产(RSA)的疗效及其护理策略。方法
选择2010年4月至2011年9月于本院确诊为RSA后完成淋巴细胞主动免疫治疗,并成功随访的154
例患者为研究对象。淋巴细胞主动免疫治疗方法为:采集配偶(健康)淋巴细胞,若配偶不宜作为免疫原提
供者,则选用无关健康个体的淋巴细胞。外周血淋巴细胞治疗方法:患者治疗前应严格避孕。将淋巴细胞
悬液1mL于患者前臂内侧分6~8点皮内注射,治疗1个疗程后检测抗磷脂抗体(APLA),每隔3~4周皮
内注射1次,4次为1个疗程。治疗1个疗程结束后,医师指导下妊娠,妊娠后继续巩固治疗1个疗程。疗
效判断标准:维持妊娠至20孕周后者判断为治愈。对接受采用淋巴细胞主动免疫治疗患者的护理策略包
括:健全登记管理制度、良好的心理疏导、严格护理操作规范(本研究遵循的程序符合本院人体试验委员会
所制定的伦理学标准,得到该委员会批准,征得受试对象本人的知情同意,并与之签署临床研究知情同意
书)。结果 ①154例RSA患者接受免疫治疗2个疗程后,APLA呈阳性为146例(94.81%),与治疗前
比较,差异有统计学意义(P<0.01)。②154例患者中,136例再次妊娠,妊娠率为88.31%;妊娠至20周
后为98例,28例在妊娠后治疗疗程中,49例足月分娩,2例早产,所产婴儿体格、智力发育正常。实施护理
策略后,患者满意度提高。结论 淋巴细胞主动免疫治疗对治疗RSA安全有效,但是否值得临床推广应
用,尚需进一步研究证实。健全登记管理制度、良好的心理疏导、严格护理操作规范、适时的健康指导等护
理策略,可提高对本病患者护理质量。
【关键词】 自然流产; 反复自然流产; 淋巴细胞免疫治疗; 护理
Effect of Lymphocytes Active Immunotherapy on Recurrent Spontaneous Abortion and its Nursing Measures
HUANG Hua-ying,SUN Hong-yan,LIAO Yun-mei. Department of Reproductive Center,Affiliated
Hospital of Luzhou Medical College,Luzhou646000,Sichuan Province,China.(Corresponding author:
HUANG Hua-ying,Email:592372827@qq.com)
【Abstract】 Objective To investigate the effect of lymphocytes active immunotherapy on recurrent
spontaneous abortion(RSA)and its nursing measures.Methods From April 2010to September 2011,a
total of 154RSA cases who underwent lymphocytes active immunotherapy treatment were included into this
study.The procedure of this treatment were the following,peripheral blood lymphocytes of husband
(healthy individuals)were collected.If the spouse should not be used as immunogen,then selected unrelated
healthy individuals lymphocytes.The standard of the efficacy was the maintenance of pregnancy to 20
gestation weeks.The nursing measures were:improve the registration and management system,good
psychological counseling and strict care practices.All of the 154patients completed the follow-up.The
study protocol was approved by the Ethical Review Board of Investigation in Human Being of Affiliated
Hospital of Luzhou Medical College.Informed consent was obtained from each participate.Results
①After receiving two courses of immune therapy,positive for anti-phospholipid antibody(APLA)was 146
cases(94.81%),there had significant difference between before and after the treatment(P<0.01).
②Among 154patients,136cases(88.31%)were re-pregnancy;pregnancy to 20weeks after the 98cases,
28cases in the course of treatment in pregnancy.Conclusions Lymphocytes active immunotherapy is safe
and effective.But whether it is worthy of clinical application,further studies are needed to confirm.The
improvement of the registration and management system,good psychological counseling,strict care
practices and timely guidance of the health care strategy can improve the quality of care to the patients.【Key words】 abortion; recurrent spontaneous abortion; lymphocyte immune therapy; nursing
DOI:10.3877/cma.j.issn.1673-5250.2012.03.014
作者单位:646000四川泸州,泸州医学院附属医院生殖部通讯作者黄华英(Email:592372827@qq.com) 对妊娠28孕周前连续发生自然流产≥3次,称为反复自然流产(recurrent spontaneous abortion,RSA),与母体缺乏抗磷脂抗体(anti-phospholipidantibody,APLA)有关,可分为免疫性RSA和非免疫
·
1
0
3
·
中华妇幼临床医学杂志(电子版)2012年6月第8卷第3期